Skip to content
Boca Raton City Online – Lifestyle
Author:
Accro Bioscience Inc.
Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona
August 13, 2026